Relationship between miR-143/145 cluster variations and cancer risk: proof from a Meta-analysis

Abstract Recent studies have suggested that single-nucleotide polymorphisms (SNPs) located in the miR-143/145 cluster might be linked to cancer risk. In this meta-analysis association study, we sought to quantitatively measure the strength of this association with cancer susceptibility in the overall analysis. Relevant publications were retrieved through a literature search in Web of Science, Medline, PubMed, Scopus, and Google scholar databases (updated January 22, 2020). Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were estimated under different genetic contrasted models. Our findings showed that rs4705341 (under allelic, codominant AA, dominant, and recessive), rs4705342 (under allelic, codominant TC, codominant CC, dominant, and recessive), and rs353292 (under allelic, codominant CT, and dominant) significantly decreased cancer risk. However, we did not find any association between the rs4705343, rs353293, rs3733845, and rs3733846 variants and cancer risk under any genetic models. The stratified analysis by cancer type showed that the rs41291957 and rs4705342 variants showed protective effects against colorectal- and prostate cancers, respectively. Our findings support the association between some miR-143/145 cluster variants and cancer risk. Replication large-scale studies on different races are encouraged to precisely delineate such associations.

[1]  R. Sheervalilou,et al.  Electrochemical Nano-biosensors as Novel Approach for the Detection of Lung Cancer-related MicroRNAs. , 2019, Current molecular medicine.

[2]  Xiao-feng Huang,et al.  Association of CD14 gene −260C>T and −561C>T polymorphisms with cancer susceptibility: A meta‐analysis , 2019, The journal of gene medicine.

[3]  D. Ivanova,et al.  Association of rs363293 single nucleotide polymorphism in promoter region of miRNA-143/145 with susceptibility to colorectal cancer and with patients’ outcome , 2019, Annals of Oncology.

[4]  Baosen Zhou,et al.  Association Between Two Polymorphisms in the Promoter Region of miR-143/miR-145 and the Susceptibility of Lung Cancer in Northeast Chinese Nonsmoking Females. , 2019, DNA and cell biology.

[5]  D. Savić-Pavićević,et al.  Analysis of association of potentially functional genetic variants within genes encoding miR-34b/c, miR-378 and miR-143/145 with prostate cancer in Serbian population , 2019, EXCLI journal.

[6]  L. Haupt,et al.  Single Nucleotide Polymorphisms in MIR143 Contribute to Protection against Non-Hodgkin Lymphoma (NHL) in Caucasian Populations , 2019, Genes.

[7]  D. Ye,et al.  Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment , 2019, Cancer management and research.

[8]  Yingfu Li,et al.  The association of polymorphisms in miRNAs with nonsmall cell lung cancer in a Han Chinese population , 2018, Cancer management and research.

[9]  Daniel Toro-Domínguez,et al.  MetaGenyo: a web tool for meta-analysis of genetic association studies , 2017, BMC Bioinformatics.

[10]  Yuan Yuan,et al.  Single nucleotide polymorphisms and cancer susceptibility , 2017, Oncotarget.

[11]  C. You,et al.  Association between functional polymorphisms in the promoter of the miR-143/145 cluster and risk of intracranial aneurysm , 2017, Scientific Reports.

[12]  J. Erler,et al.  Dynamics of cancerous tissue correlates with invasiveness , 2017, Scientific Reports.

[13]  Yu-qin Pan,et al.  MiR-608, pre-miR-124-1 and pre-miR26a-1 polymorphisms modify susceptibility and recurrence-free survival in surgically resected CRC individuals , 2016, Oncotarget.

[14]  Peng Chen,et al.  A polymorphism rs4705341 in the flanking region of miR-143/145 predicts risk and prognosis of colorectal cancer , 2016, Oncotarget.

[15]  Lin Zhang,et al.  A functional variant rs353292 in the flanking region of miR-143/145 contributes to the risk of colorectal cancer , 2016, Scientific Reports.

[16]  Jun Wu,et al.  A Functional rs353293 Polymorphism in the Promoter of miR-143/145 Is Associated with a Reduced Risk of Bladder Cancer , 2016, PloS one.

[17]  Hongbing Shen,et al.  Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk , 2016, Oncotarget.

[18]  Baosheng Li,et al.  RETRACTED: MiR-143 inhibits tumor cell proliferation and invasion by targeting STAT3 in esophageal squamous cell carcinoma. , 2016, Cancer letters.

[19]  G. Calin,et al.  The miR-143/miR-145 cluster and the tumor microenvironment: unexpected roles , 2016, Genome Medicine.

[20]  Weibo Liang,et al.  A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women , 2015, Medicine.

[21]  H. Lilja,et al.  miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis. , 2015, Carcinogenesis.

[22]  Hongyu Zhao,et al.  Quantitative assessment of pre-miR-218 rs11134527 polymorphism and cancer risk in Chinese population , 2015, OncoTargets and therapy.

[23]  Na Li,et al.  Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion , 2015, PloS one.

[24]  R. Gregory,et al.  MicroRNA biogenesis pathways in cancer , 2015, Nature Reviews Cancer.

[25]  I. Soerjomataram,et al.  Measuring the societal burden of cancer: The cost of lost productivity due to premature cancer‐related mortality in Europe , 2015, International journal of cancer.

[26]  Feiran Wang,et al.  MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells. , 2015, International journal of clinical and experimental pathology.

[27]  J. Li,et al.  A functional variant in miR-143 promoter contributes to prostate cancer risk , 2014, Archives of Toxicology.

[28]  Jianning Zhao,et al.  MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion , 2014, Tumor Biology.

[29]  N. Wu,et al.  MicroRNA-145 Function as a Cell Growth Repressor by Directly Targeting c-Myc in Human Ovarian Cancer , 2014, Technology in cancer research & treatment.

[30]  Lin Zhang,et al.  Association between polymorphisms in the promoter region of miR-143/145 and risk of colorectal cancer. , 2013, Human immunology.

[31]  N. Parsa,et al.  Environmental Factors Inducing Human Cancers , 2012, Iranian journal of public health.

[32]  Min Su,et al.  miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2. , 2011, Molecular medicine reports.

[33]  G. Calin,et al.  MicroRNA history: discovery, recent applications, and next frontiers. , 2011, Mutation research.

[34]  Q. Pan,et al.  MicroRNA-143 as a tumor suppressor for bladder cancer. , 2009, The Journal of urology.

[35]  C. Hother,et al.  MicroRNAs and cancer , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[36]  Mariette Schrier,et al.  A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors , 2006, Cell.

[37]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[38]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[39]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[40]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[41]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[42]  P. Langhorne,et al.  graphical test Bias in meta-analysis detected by a simple, , 2009 .